Synthorx, Inc.. (THOR) NASDAQ
$67.99 0 (0.00%)
Market Cap: $2.20B
As of 01/22/20 12:00 AM EST. Market closed.
Synthorx, Inc.. (THOR)
NASDAQ
$67.99
0 (0.00%)
Market Cap: $2.20B
As of 01/22/20 12:00 AM EST. Market closed.
Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, ... read more
Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. read less
COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO Compensation (Base)
$430,125
CEO Compensation (Total)
$5.21M
Sector
Health Technology
Industry
Biotechnology
Full Time Employees
38
CEO Compensation (Base)
$430,125
CEO Compensation (Total)
$5.21M
URL
Address
.
PRICE CHART FOR SYNTHORX, INC.
From:
To:
NEWS
KEY STATS
Open
$0
Previous Close
$67.99
Days Range
$0 - $0
52 week range
$11.05 - $71.90
Volume
0
Avg. Volume (30 days)
502,510
Market Cap
$2.20B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,338,000
Open
$0
Previous Close
$67.99
Days Range
$0 - $0
52 week range
$11.05 - $71.90
Volume
0
Avg. Volume (30 days)
502,510
Market Cap
$2.20B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,338,000
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SYNTHORX, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Thompson Peter A. | Director | Jan 23, 2020 | Option Exercise | $68.00 | 5,316,355 | 361,512,140 | 0 | Jan 24, 2020, 06:44 PM |
| Shawver Laura | President and CEO | Jan 23, 2020 | Option Exercise | $68.00 | 25,000 | 1,700,000 | 0 | Jan 24, 2020, 06:41 PM |
| Shawver Laura | President and CEO | Jan 23, 2020 | Option Exercise | $68.00 | 220,595 | 15,000,460 | 0 | Jan 24, 2020, 06:41 PM |
| Shah Pratik | Director | Jan 23, 2020 | Option Exercise | $68.00 | 62,412 | 4,244,016 | 0 | Jan 24, 2020, 06:38 PM |
| Reardon Tighe | Acting Chief Financial Officer | Jan 23, 2020 | Option Exercise | $68.00 | 1,682,086 | 114,381,848 | 0 | Jan 24, 2020, 06:36 PM |
| Reardon Tighe | Acting Chief Financial Officer | Jan 23, 2020 | Option Exercise | $68.00 | 43,688 | 2,970,784 | 0 | Jan 24, 2020, 06:36 PM |
| Milla Marcos | Chief Scientific Officer | Jan 23, 2020 | Option Exercise | $68.00 | 63,989 | 4,351,252 | 0 | Jan 24, 2020, 06:31 PM |
| Lichter Jay | Director | Jan 23, 2020 | Option Exercise | $68.00 | 1,682,086 | 114,381,848 | 0 | Jan 24, 2020, 06:28 PM |
| Lichter Jay | Director | Jan 23, 2020 | Option Exercise | $68.00 | 448,567 | 30,502,556 | 0 | Jan 24, 2020, 06:28 PM |
| Lichter Jay | Director | Jan 23, 2020 | Option Exercise | $68.00 | 150,000 | 10,200,000 | 0 | Jan 24, 2020, 06:28 PM |
| Leveque Joseph | Chief Medical Officer | Jan 23, 2020 | Option Exercise | $68.00 | 316,164 | 21,499,152 | 0 | Jan 24, 2020, 06:26 PM |
| Kolchinsky Peter | Director | Jan 23, 2020 | Option Exercise | $68.00 | 9,724,598 | 661,272,664 | 0 | Jan 24, 2020, 06:23 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jan 23, 2020 | Option Exercise | $68.00 | 9,724,598 | 661,272,664 | 0 | Jan 24, 2020, 05:53 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jan 23, 2020 | Option Exercise | $68.00 | 9,724,598 | 661,272,664 | 0 | Jan 24, 2020, 05:11 PM |
| Leveque Joseph | Chief Medical Officer | Dec 30, 2019 | Option Exercise | $70.63 | 45,019 | 3,179,692 | 313,891 | Jan 02, 2020, 04:43 PM |
| Leveque Joseph | Chief Medical Officer | Dec 30, 2019 | Option Exercise | $11.00 | 75,000 | 825,000 | 358,910 | Jan 02, 2020, 04:43 PM |
| Milla Marcos | Chief Scientific Officer | Dec 30, 2019 | Option Exercise | $70.63 | 52,011 | 3,673,537 | 63,989 | Jan 02, 2020, 04:41 PM |
| Milla Marcos | Chief Scientific Officer | Dec 30, 2019 | Option Exercise | $0.63 | 98,000 | 61,740 | 116,000 | Jan 02, 2020, 04:41 PM |
| Shawver Laura | President and CEO | Dec 30, 2019 | Option Exercise | $70.63 | 210,010 | 14,833,006 | 296,301 | Jan 02, 2020, 04:39 PM |
| Shawver Laura | President and CEO | Dec 30, 2019 | Option Exercise | $4.02 | 379,453 | 1,525,319 | 506,311 | Jan 02, 2020, 04:39 PM |
| Shawver Laura | President and CEO | Jan 24, 2019 | Option Exercise | $0.63 | 25,000 | 15,750 | 25,000 | Jan 25, 2019, 04:33 PM |
| Thompson Peter A. | Director | Dec 11, 2018 | Buy | $11.00 | 1,363,636 | 14,999,996 | 5,316,355 | Dec 13, 2018, 06:37 PM |
| Reardon Tighe | Acting Chief Financial Officer | Dec 11, 2018 | Buy | $11.00 | 545,455 | 6,000,005 | 1,682,086 | Dec 13, 2018, 06:36 PM |
| Lichter Jay | Director | Dec 11, 2018 | Buy | $11.00 | 545,455 | 6,000,005 | 1,682,086 | Dec 13, 2018, 06:35 PM |
| ORBIMED ADVISORS LLC | Director | Dec 11, 2018 | Buy | $11.00 | 1,363,636 | 14,999,996 | 1,363,636 | Dec 13, 2018, 06:33 PM |
| Kolchinsky Peter | Director | Dec 11, 2018 | Buy | $11.00 | 4,545,455 | 50,000,005 | 9,724,598 | Dec 13, 2018, 06:31 PM |
| Avalon Ventures X, L.P. | 10% Owner | Dec 11, 2018 | Buy | $11.00 | 545,455 | 6,000,005 | 1,682,086 | Dec 13, 2018, 06:30 PM |
| RA CAPITAL MANAGEMENT, LLC | 10% Owner | Dec 11, 2018 | Buy | $11.00 | 4,545,455 | 50,000,005 | 9,724,598 | Dec 13, 2018, 06:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Thompson Peter A. | Director | 01/23/2020 | 361,512,140 |
| Shawver Laura | President and CEO | 01/23/2020 | 1,700,000 |
| Shawver Laura | President and CEO | 01/23/2020 | 15,000,460 |
| Shah Pratik | Director | 01/23/2020 | 4,244,016 |
| Reardon Tighe | Acting Chief Financial Officer | 01/23/2020 | 114,381,848 |
| Reardon Tighe | Acting Chief Financial Officer | 01/23/2020 | 2,970,784 |
| Milla Marcos | Chief Scientific Officer | 01/23/2020 | 4,351,252 |
| Lichter Jay | Director | 01/23/2020 | 114,381,848 |
| Lichter Jay | Director | 01/23/2020 | 30,502,556 |
| Lichter Jay | Director | 01/23/2020 | 10,200,000 |
| Leveque Joseph | Chief Medical Officer | 01/23/2020 | 21,499,152 |
| Kolchinsky Peter | Director | 01/23/2020 | 661,272,664 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 01/23/2020 | 661,272,664 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 01/23/2020 | 661,272,664 |
| Leveque Joseph | Chief Medical Officer | 12/30/2019 | 3,179,692 |
| Leveque Joseph | Chief Medical Officer | 12/30/2019 | 825,000 |
| Milla Marcos | Chief Scientific Officer | 12/30/2019 | 3,673,537 |
| Milla Marcos | Chief Scientific Officer | 12/30/2019 | 61,740 |
| Shawver Laura | President and CEO | 12/30/2019 | 14,833,006 |
| Shawver Laura | President and CEO | 12/30/2019 | 1,525,319 |
| Shawver Laura | President and CEO | 01/24/2019 | 15,750 |
| Thompson Peter A. | Director | 12/11/2018 | 14,999,996 |
| Reardon Tighe | Acting Chief Financial Officer | 12/11/2018 | 6,000,005 |
| Lichter Jay | Director | 12/11/2018 | 6,000,005 |
| ORBIMED ADVISORS LLC | Director | 12/11/2018 | 14,999,996 |
| Kolchinsky Peter | Director | 12/11/2018 | 50,000,005 |
| Avalon Ventures X, L.P. | 10% Owner | 12/11/2018 | 6,000,005 |
| RA CAPITAL MANAGEMENT, LLC | 10% Owner | 12/11/2018 | 50,000,005 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR SYNTHORX, INC.
STOCK BUYBACKS FOR SYNTHORX, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 09/30/2019
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2019
0.31%
1Q